Todavía no hay suficientes señales de compra con un horizonte T+90 consolidado para medir un historial.
Historial de señales
Explore the full record of transactions filed by Coleman Glenn, Director General. Officer active across 4 companies, notably Integra Lifesciences Holdings CORP. Cumulatively, 27 filings have been recorded. Breakdown: 1 buy · 2 sells. Total volume traded: €922k. History available since 2 November 2021. The latest transaction was disclosed on 29 May 2026 (Attribution). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Coleman Glenn
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Coleman Glenn is Directeur Général. He has 27 filings in total, and across the recent sample of 27 filings, the transaction amounts run from 2021-11-03 to 2026-06-02, with EUR 272301 of buys and EUR 4609348 of sells. The recent filings concern DENTSPLY SIRONA Inc., Premier, Inc., Integra Lifesciences Holdings CORP and Charles River Laboratories International, INC., and his most frequent transaction nature is Attribution.